Recent Advances in Enterovirus A71 Infection and Antiviral Agents.
Wei Y, Liu H, Hu D, He Q, Yao C, Li H, Hu K, Wang J.
Lab Invest. 2024 Feb;104(2):100298. doi: 10.1016/j.labinv.2023.100298. Epub 2023 Nov 25.
PMID:38008182
Severe coxsackie virus B5 encephalitis mimics autoimmune limbic encephalitis in a young woman under long-term B-cell depletion with ocrelizumab: A case report.
Stögbauer J, Schegerer V, Berger FK, Schulz-Schaeffer W, Fassbender K, Naumann J, Smola S, Eisenbeis J, Bewarder M, Rosar F, Kettner M, Gilcher T, Diedrich S, Fousse M.
Mult Scler. 2025 Sep;31(10):1258-1261. doi: 10.1177/13524585251322327. Epub 2025 Feb 27.
PMID:40012477
Brainstem encephalitis caused by Coxsackie A16 virus in a rituximab-immunosuppressed patient.
Cameron Smail R, O'Neill JH, Andresen D.
BMJ Case Rep. 2019 Aug 26;12(8):e230177. doi: 10.1136/bcr-2019-230177.
PMID:31451462
Coxsackie virus B 4 encephalitis in a 7 year old boy.
Messacar K, Fischer M, Dominguez SR, Tyler KL, Abzug MJ.
Infect Dis Clin North Am. 2018 Mar;32(1):145-162. doi: 10.1016/j.idc.2017.10.007. Epub 2017 Dec 8.
PMID:29224854
Enterovirus pathogenesis requires the host methyltransferase SETD3.
Diep J, Ooi YS, Wilkinson AW, Peters CE, Foy E, Johnson JR, Zengel J, Ding S, Weng KF, Laufman O, Jang G, Xu J, Young T, Verschueren E, Kobluk KJ, Elias JE, Sarnow P, Greenberg HB, Hüttenhain R, Nagamine CM, Andino R, Krogan NJ, Gozani O, Carette JE.